University of California San Francisco
Helen Diller Family Comprehensive Cancer Center
Raj Pruthi, MD, MHA, FACS

Raj Pruthi, MD, MHA, FACS

Professor and Chair, Department of Urology, UCSF

Cancer Center Program Memberships

Prostate Cancer


  • BA, 1988, Stanford University, Economics
  • BS, 1988, Stanford University, Biology
  • MD, 1992, Duke University, Durham, NC
  • Residency, 1992-1994, General Surgery, Stanford University, Stanford, CA
  • Residency, 1994-1998, Urologic Surgery, Stanford University, Stanford, CA
  • Masters of Health Administration, 2017, University of North Carolina at Chapel Hill

Professional Experience

  • 2020 - Present
    Professor and Chair, Department of Urology, UCSF
  • 2017- 2019
    Department Chair, John Rhodes Distinguished Professor of Urology (tenure), Department of Urology, UNC School of Medicine, Chapel Hill
  • 2013 - 2017
    Department Chair, Professor of Urology (tenure), Department of Urology, UNC School of Medicine, Chapel Hill
  • 2011 - 2013
    Division Chief, Professor of Surgery (tenure), Division of Urology, UNC School of Medicine, Chapel Hill
  • 2011 - 2011
    Division Chief, Associate Professor of Surgery (tenure), Division of Urology, UNC School of Medicine, Chapel Hill
  • 2006 - 2011
    Associate Professor of Surgery (tenure), Division of Urology, UNC School of Medicine, Chapel Hill
  • 2000 - 2006
    Assistant Professor of Surgery, Division of Urology, UNC School of Medicine, Chapel Hill
  • 1999 - 2000
    Assistant Professor of Urology, Dept. of Urology, LSU Medical Center, Shreveport, Louisiana 
  • 1998 - 1999
    Private Practice of Urology, Kinston Urological Associates, Kinston, North Carolina 

Honors & Awards

  • 2018, 2016, 2015
    UNC Health Care and Faculty Physicians Award for Carolina Care Excellence
  • 2018, 2017, 2016, 2015, 2014, 2013, 2011-2012, 2007-2008, 2006-2007, 2005-2006, 2004-2005, 2003-04
    "Best Doctors in America"
  • 2012, 2010-2011
    Castle and Connolly's "America's Top Doctors"
  • 2011-2012
    Faculty Teaching Award ("Attending of the Year"), Division of Urologic Surgery
  • 2010-2011
    America's Top Doctors for Cancer
  • 2010
    "Best Doctors in North Carolina"

Selected Publications

  1. Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, Odisho AY. Rapid Utilization of Telehealth in a Comprehensive Cancer Center as a Response to COVID-19. J Med Internet Res. 2020 Jun 21.
    View on PubMed
  2. Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS, Weizer AZ, Konety BR, Tollefson M, Krupski TL, Smith ND, Shabsigh A, Barocas DA, Quek ML, Dash A, Kibel AS, Shemanski L, Pruthi RS, Montgomery JS, Weight CJ, Sharp DS, Chang SS, Cookson MS, Gupta GN, Gorbonos A, Uchio EM, Skinner E, Venkatramani V, Soodana-Prakash N, Kendrick K, Smith JA, Thompson IM. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018 06 23; 391(10139):2525-2536.
    View on PubMed
  3. Lotan Y, Black PC, Caba L, Chang SS, Cookson MS, Daneshmand S, Kamat AM, McKiernan JM, Pruthi RS, Ritch CR, Steinberg GD, Svatek RS, Zwarthoff EC. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review. Eur Urol Oncol. 2018 08; 1(3):223-230.
    View on PubMed
  4. Pruthi RS, Filippou P. Editorial Comment. Urology. 2017 06; 104:83.
    View on PubMed
  5. Smith AB, Crowell K, Woods ME, Wallen EM, Pruthi RS, Nielsen ME, Lee CT. Functional Outcomes Following Radical Cystectomy in Women with Bladder Cancer: A Systematic Review. Eur Urol Focus. 2017 02; 3(1):136-143.
    View on PubMed
  6. Rose TL, Deal AM, Basch E, Godley PA, Rathmell WK, Kim WY, Whang YE, Dunn MW, Wang A, Chen RC, Nielsen ME, Pruthi RS, Wallen EM, Woods ME, Smith AB, Milowsky MI. Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settings. Urol Oncol. 2015 Sep; 33(9):386.e1-6.
    View on PubMed
  7. Johnson DC, Riggs SB, Nielsen ME, Matthews JE, Woods ME, Wallen EM, Pruthi RS, Smith AB. Nutritional predictors of complications following radical cystectomy. World J Urol. 2015 Aug; 33(8):1129-37.
    View on PubMed
  8. Pruthi RS, Raynor MC. Enhanced recovery programmes: an important step towards going lean in healthcare. BJU Int. 2014 May; 113(5):685-6.
    View on PubMed
  9. Smith AB, Deal AM, Woods ME, Wallen EM, Pruthi RS, Chen RC, Milowsky MI, Nielsen ME. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base. BJU Int. 2014 Nov; 114(5):719-26.
    View on PubMed
  10. Smith AB, Deal AM, Yu H, Boyd B, Matthews J, Wallen EM, Pruthi RS, Woods ME, Muss H, Nielsen ME. Sarcopenia as a predictor of complications and survival following radical cystectomy. J Urol. 2014 Jun; 191(6):1714-20.
    View on PubMed
  11. Nielsen ME, Smith AB, Meyer AM, Kuo TM, Tyree S, Kim WY, Milowsky MI, Pruthi RS, Millikan RC. Trends in stage-specific incidence rates for urothelial carcinoma of the bladder in the United States: 1988 to 2006. Cancer. 2014 Jan 01; 120(1):86-95.
    View on PubMed
  12. Song L, Chen RC, Bensen JT, Knafl GJ, Nielsen ME, Farnan L, Wallen EM, Mishel M, Pruthi RS, Mohler JL, Godley PA. Who makes the decision regarding the treatment of clinically localized prostate cancer--the patient or physician?: results from a population-based study. Cancer. 2013 Jan 15; 119(2):421-8.
    View on PubMed
  13. Mmeje CO, Nunez-Nateras R, Nielsen ME, Pruthi RS, Smith A, Wallen EM, Humphreys MR, Woods ME, Castle EP. Oncologic outcomes for lymph node-positive urothelial carcinoma patients treated with robot assisted radical cystectomy: with mean follow-up of 3.5 years. Urol Oncol. 2013 Nov; 31(8):1621-7.
    View on PubMed
  14. Pruthi RS, Nielsen ME, Nix J, Smith A, Schultz H, Wallen EM. Robotic radical cystectomy for bladder cancer: surgical and pathological outcomes in 100 consecutive cases. J Urol. 2010 Feb; 183(2):510-4.
    View on PubMed
  15. Pruthi RS, Lentz AC, Sand M, Kouba E, Wallen EM. Impact of marital status in patients undergoing radical cystectomy for bladder cancer. World J Urol. 2009 Aug; 27(4):573-6.
    View on PubMed
  16. Kouba EJ, Lentz A, Wallen EM, Pruthi RS. Clinical use of serum CA-125 levels in patients undergoing radical cystectomy for transitional cell carcinoma of the bladder. Urol Oncol. 2009 Sep-Oct; 27(5):486-90.
    View on PubMed
  17. Pruthi RS, Baldwin N, Bhalani V, Wallen EM. Conservative management of low risk superficial bladder tumors. J Urol. 2008 Jan; 179(1):87-90; discussion 90.
    View on PubMed
  18. Pruthi RS, Wallen EM. Robotic assisted laparoscopic radical cystoprostatectomy: operative and pathological outcomes. J Urol. 2007 Sep; 178(3 Pt 1):814-8.
    View on PubMed
  19. Small EJ, Halabi S, Dalbagni G, Pruthi R, Phillips G, Edelman M, Bajorin D. Overview of bladder cancer trials in the Cancer and Leukemia Group B. Cancer. 2003 Apr 15; 97(8 Suppl):2090-8.
    View on PubMed
  20. Pruthi RS, Petrus CD, Bundrick WS JR. New onset vesicovaginal fistula after transurethral collagen injection in women who underwent cystectomy and orthotopic neobladder creation: presentation and definitive treatment. J Urol. 2000 Nov; 164(5):1638-9.
    View on PubMed

Go to UCSF Profiles, powered by CTSI